News
Brief news reports on Tuberculosis
By
Médecins Sans Frontières
Published: Nov. 23, 2013, 8:48 p.m.·
Tags:
None
Read More →
By
Treatment Action Group
Published: Nov. 23, 2013, 8:38 p.m.·
Tags:
None
Approval of and access to delamanid are crucial while further research is pending.
Read More →
By
European Medicines Agency
Published: Nov. 23, 2013, 8:31 p.m.·
Tags:
None
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the authorisation of Deltyba (delamanid) and Para-aminosalicylic acid Lucane (para-aminosalicylic acid), two treatment options for use in combination with other medicines against multidrug-resistant tuberculosis.
Read More →
By
Theo Smart
Published: Nov. 23, 2013, 6 p.m.·
Tags:
None
The TB community - clearly driven by TB/HIV activism - is now calling for a global effort to eliminate TB: "We are demanding that you all in this room have vision, that you all in this room decide that we are not going to control TB, but we are going to eliminate TB." (Colleen Daniels, TAG)
Read More →
By
Jaine Roberts
Published: Nov. 21, 2013, 1:18 p.m.·
Tags:
None
TB is linked with a deadly silicosis epidemic hidden for decades in rural South Africa. Gold mining firms must make amends, says Jaine Roberts.
Read More →
By
Rabita Aziz
Published: Nov. 21, 2013, 1:15 p.m.·
Tags:
None
How do you reach the three million people who become ill with tuberculosis every year, but go undetected, suffering and dying needlessly, while infecting others? The answer is simple: take a risk. TB REACH, a program of the Stop TB Partnership, has embraced the “inherent risk of innovation” to find new, more effective approaches to TB case detection, which are tailored uniquely to reach different vulnerable populations.
Read More →
By
Antigone Barton
Published: Nov. 20, 2013, 11:57 p.m.·
Tags:
None
Bipartisan, bicameral legislation extends U.S. Leadership Act, confirming ongoing commitments to PEPFAR and the Global Fund as well as to bilateral responses to AIDS, Tuberculosis and Malaria
Read More →
By
Linda Daniels
Published: Nov. 20, 2013, 10:35 p.m.·
Tags:
None
CAPE TOWN – The much-anticipated process of public submissions into the draft South Africa National Intellectual Property Policy has come to a close. The country’s trade minister says the office is busy collating the 100 documents submitted by interested stakeholders and plans to submit a formal policy to cabinet for approval in the first quarter of next year.
Read More →
By
Mail & Guardian
Published: Nov. 20, 2013, 10:15 p.m.·
Tags:
None
A slideshow from the Mail & Guardian asks if we are paying enough attention to TB:
Read More →
By
Treatment Action Campaign
Published: Nov. 20, 2013, 8:22 p.m.·
Tags:
None
Janssen must run a Phase III trial of bedaquiline urgently; More investment in TB drugs and diagnostics urgently needed.
Read More →
Page 683 of 878 · Total posts: 10
←First
682
683
684
Last→